Our Studies

AvenActive
  • Population: Healthy subject
  • N. of Participants: 96
  • Study Type: Interventional Drug
  • Status: Recruiting
  • Sponsor: CEAPRO Inc.
  • AvenActive
APL
  • Population: Acute promyelocytic Leukemia
  • N. of Participants: 40-50/year
  • Study Type: Canadian Registry
  • Status: Recruiting
BRAIN-AF
  • Population: Atrial Fibrillation
  • N. of Participants: 1424
  • Study Type: Interventional Drug
  • Status: Recruiting
  • https://brain-af.ca/en/
CAPTURE
  • Population: Atrial Fibrillation
  • N. of Participants: 200
  • Study Type: Registry
  • Status: No longer recruiting
Carchem
  • Population: Cardio-oncology
  • N. of Participants: 300
  • Study Type: Observational
  • Status: Recruiting
CD-IT
  • Population: Crohn's Disease
  • N. of Participants: 68
  • Study Type: Interventional Drug
  • Status: Recruiting
Biobank
  • Population: Cardiology
  • N. of Participants: 30 000
  • Study Type: Registry
  • Status: Recruiting
Colcot T2d
  • Population: Diabetes
  • N. of Participants: 10 000
  • Study Type: Interventional Drug
  • Status: Recruiting
  • https://colcot-t2d.org/en
CONCEPT
  • Population: Heart Failure
  • N. of Participants: 20
  • Study Type: Interventional Device
  • Status: No longer recruiting
  • Sponsor: Inogen, Inc
ECT
  • Population: Leukemia
  • N. of Participants: 30
  • Study Type: Interventional Drug
  • Status: No longer recruiting
EVOLVE
  • Population: Heart Failure
  • N. of Participants: 174
  • Study Type: Interventional Device
  • Status: Recruiting
Hiro HCM
  • Population: Hypertrophic Cardiomyopathy
  • N. of Participants: 1200
  • Study Type: Canadian Registry
  • Status: Recruiting
IM_quebec
  • Population: Segment T Elevation Myocardial Infacrtion in Quebec province
  • N. of Participants: 3000/year
  • Study Type: Quebec Registry
  • Status: Recruiting
MITNEC_C6
  • Population: Alzheimer and strokes
  • N. of Participants: 80
  • Study Type: Observational
  • Status: Active
PCIGVHD
  • Population: Leukemia
  • N. of Participants: 150
  • Study Type: Observational
  • Status: No longer recruiting
Restore
  • Population: Long Covid
  • N. of Participants: 20
  • Study Type: Interventional Device
  • Status: No longer recruiting
  • Sponsor: Inogen, Inc
Revera
  • Population: Atrial Fibrillation
  • N. of Participants: 50
  • Study Type: Interventional Drug
  • Status: No longer recruiting
  • Sponsor: Milestone Pharmaceuticals, Inc
Selfie
  • Population: Heart Failure
  • N. of Participants: 150
  • Study Type: Interventional Device
  • Status: Recruiting
STAR-AF-III
  • Population: Atrial Fibrillation
  • N. of Participants: 600
  • Study Type: Interventional Procedure
  • Status: Recruiting
  • Sponsor: The Research Institute of the McGill University Health Centre
Take it too P3
  • Population: Juvenile and Teens Kidney Transplant
  • N. of Participants: 67
  • Study Type: Interventional Device
  • Status: No longer recruiting
HBI-3000-402
  • Population: Atrial Fibrillation
  • N. of Participants: 150-160
  • Study Type: Interventional Drug
  • Status: No longer recruiting
  • Sponsor: HUYABIO INTERNATIONAL, LLC

If you are conducting or are interested in conducting clinical studies as a Sponsor, Investigator or Study Coordinator, please contact us:

Telephone : 514-461-1300
Email : contact@mhicc.org

Contact Us